Status:
TERMINATED
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
Lead Sponsor:
University of New Mexico
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Chart Review of patients with pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Detailed Description
Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Eligibility Criteria
Inclusion
- Patients with unresectable/metastatic pancreatic cancer treated in the UNM Cancer Research and Treatment Center.
Exclusion
- Not specified.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00322712
Start Date
September 1 2006
End Date
January 1 2007
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131